+1 Recommend
1 collections
      • Record: found
      • Abstract: found
      • Article: found

      Effect of Dextran Infusion on Left Atrial Size in Normal Subjects

      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.


          The purpose of this study was to evaluate left atrium dimension during acute volume loading. Low molecular weight dextran solution (1,000 ml) was continuously infused in 10 subjects without cardiac disease. Measurements of pulmonary arterial, capillary wedge, right atrial and systemic blood pressures, cardiac output, heart rate and M-mode left atrial maximum diameter were made in basal conditions and after 250, 500, 750 and 1,000 ml of dextran. In 4 subjects a two-dimensional echocardiogram was also obtained in the short axis and four-chamber views. Dextran produced the following changes (mean values ± standard deviation) in haemodynamic variables: right atrial and wedge pressures increased from 3.2 ± 1.55 to 12.3 ± 3.08 mm Hg (p < 0.001) and from 6.9 ± 1.45 to 20.6 ± 3.44 mm Hg (p < 0.001), respectively. Stroke volume increased from 70.5 ± 31.6 to 86.6 ± 24.6 ml/beat (p < 0.05). Heart rate increased from 81.0 ± 15.8 to 95.0 ± 12.3 beats/min (p < 0.05). Left atrial maximum diameter showed a slight incrase after 500 ml of dextran (from 39.5 ± 4.1 to 43.6 ± 5.0 mm, p < 0.05). It did not further increase by continuing the infusion up to 1,000 ml despite the marked increase in wedge pressure. The results show that left atrial size is partly independent of haemodynamic changes and that the compliance of the left atrium is relatively low. This finding is consistent with the common clinical observation that the left atrium is only slightly enlarged in acute mitral insufficiency.

          Related collections

          Author and article information

          S. Karger AG
          07 November 2008
          : 69
          : 5
          : 257-264
          Cardiology Unit, University of Florence, Italy
          173514 Cardiology 1982;69:257–264
          © 1982 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          Page count
          Pages: 8
          Original Paper


          Comment on this article